FDA approves first MS-specific drug
135618
(National-NBC) Nov. 24, 2004 - The Food and Drug Administration has approved the first drug that specifically targets Multiple Sclerosis.
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
653673
A new drug that can treat patients with multiple sclerosis has been approved by the Food and Drug Administration but the high cost of the medication has some people concerned.
64073
Tysabri, a treatment for multiple sclerosis, received regulatory approval on Monday for use among patients with Crohnâs disease.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
603982
The US Food and Drug Administration has approved Tysabri (natalizumab) as a new treatment for multiple sclerosis. The incurable nervous system disease affects about 350,000 Americans.
511329
Canadian regulators have given initial approval to a cannabis-based drug to treat patients suffering from multiple sclerosis, Reuters reported Dec. 21.
668940
Sanofi Pasteur MSD says it has won approval to begin selling Gardasil, the first vaccine against cervical cancer, in Europe.
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.
357627
A top compound in development could become an important MS treatment.
367403
Pharmaceutical firm Wyeth said Tuesday that the Food and Drug Administration granted fast-track status to its experimental cancer drug temsirolimus as an initial treatment for patients with advanced kidney cancer.
748585
ATLANTA -- A new device that was studied in Atlanta has been approved by the US Food and Drug Administration to help stroke victims.
667096
The biotech's new cancer candidate passes phase 1 trials.
564004
Tysabri, a treatment for multiple sclerosis made by Biogen Idec Inc. and Elan Corp., received regulatory approval on Monday for use among patients with a severe intestinal disorder.
384223
The US Food and Drug Administration has approved the first over-the-counter diet drug, a lower dose version of a prescription drug made by British firm GlaxoSmithKline.
62500
Genzyme Corp. won approval Wednesday for a childhood leukemia drug under an accelerated government approval process for potentially lifesaving treatments.